NVDA
NVIDIA
-- 135.910 RGTI
Rigetti Computing
-- 8.9300 TSLA
Tesla
-- 394.740 AMD
Advanced Micro Devices
-- 116.040 PLTR
Palantir
-- 67.260 
WUXI BIO Foresees 1H23 Rev. Growth to Decelerate, Maintains Full-yr Guidance
$WUXI BIO (02269.HK)$ 's share price plummeted 17% yesterday to wrap up the session at $38.75. The company announced this morning that it has convened an Investor Day today and conducted a presentation containing financial and other information regarding the Company’s business operations.
The Company reiterated that the Company’s business operation remains normal, and that there has been no material adverse change to its business operation and financial position.
Due to high base in 1H22 and shutdown for maintenance after three years of bullet train speed, 1H23 will likely see slower revenue growth, the company added. The firm, despite all challenges, maintained the full year guidance.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 countdown: What's the next big opportunity in the markets?
Trump is gearing up for a return to the political stage, and his "America First" tariff policies, along with his stance on cryptocurrency an
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day